Table 2.
The severity of dysmenorrhea, dyspareunia, and chronic pelvic pain according to the extension of disease
| Variable | Total | Minimal No. (%)a |
Mild No. (%)a |
Moderate No. (%)a |
Severe No. (%)a |
p |
|---|---|---|---|---|---|---|
| Dysmenorrhea severity | 0.8 | |||||
| The cumulative size of DIE implants | ||||||
| < 1 cm | 22 | 0 | 2 (9.1) | 9 (40.9) | 11 (50) | |
| 1–3 cm | 47 | 1 (2.1) | 4 (8.5) | 19 (40.4) | 23 (48.9) | |
| > 3 cm | 41 | 2 (4.9) | 4 (9.8) | 11 (26.8) | 24 (58.5) | |
| The cumulative surface of superficial peritoneal implants | 0.48 | |||||
| 0 | 142 | 4 (2.8) | 16 (11.3) | 40 (28.2) | 82 (57.7) | |
| < 3 cm | 5 | 0 | 1 (20) | 3 (60) | 1 (20) | |
| > 3 cm | 5 | 0 | 0 | 2 (40) | 3 (60) | |
| Endometrioma | 0.53 | |||||
| None | 28 | 0 | 2 (7.1) | 5 (17.9) | 21 (75) | |
| Unilateral | 78 | 3 (3.8) | 12 (15.4) | 22 (28.2) | 41 (52.6) | |
| Bilateral | 51 | 1 (2) | 3 (5.9) | 18 (35.3) | 29 (56.9) | |
| Cumulative size of endometriomas | 0.31 | |||||
| 0 | 28 | 0 | 2 (7.1) | 5 (17.9) | 21 (75) | |
| ≤ 3 cm | 26 | 2 (7.7) | 5 (19.2) | 6 (23.1) | 13 (50) | |
| > 3 cm | 100 | 2 (2) | 10 (10) | 34 (34) | 54 (54) | |
| Size of the largest endometrioma | 0.69 | |||||
| 0 | 26 | 0 | 2 (7.7) | 5 (19.2) | 19 (73.1) | |
| ≤ 3 cm | 43 | 2 (4.7) | 5 (11.6) | 14 (32.6) | 22 (51.2) | |
| > 3 cm | 85 | 2 (2.4) | 10 (11.8) | 26 (30.6) | 47 (55.3) | |
| Douglas obliteration | 0.42 | |||||
| Absent | 21 | 0 | 3 (14.3) | 7 (33.3) | 11 (52.4) | |
| Partial | 53 | 3 (5.7) | 7 (13.2) | 11 (20.8) | 32 (60.4) | |
| Complete | 75 | 1 (1.3) | 7 (9.3) | 27 (36) | 40 (53.3) | |
| Cumulative size of posterior DIE | 0.7 | |||||
| < 1 cm | 22 | 0 | 2 (9.1) | 9 (40.9) | 11 (50) | |
| 1–3 cm | 46 | 1 (2.2) | 3 (6.5) | 19 (41.3) | 23 (50) | |
| > 3 cm | 40 | 2 (5) | 4 (10) | 10 (25) | 24 (60) | |
| Sub peritoneal extension | 0.82 | |||||
| Sub-peritoneal only | 92 | 2 (2.2) | 10 (10.9) | 27 (29.3) | 53 (57.6) | |
| Rectal | 51 | 2 (3.9) | 5 (9.8) | 16 (31.4) | 28 (54.9) | |
| Vaginal | 1 | 0 | 0 | 1 (100) | 0 | |
| Both rectal and vaginal | 2 | 0 | 0 | 0 | 2 (100) | |
| Dyspareunia severity | ||||||
| Cumulative size of DIE implants | ||||||
| < 1 cm | 16 | 10 (62.5) | 3 (18.8) | 1 (6.3) | 2 (12.5) | 0.05 |
| 1–3 cm | 36 | 13 (36.1) | 4 (11.1) | 9 (25) | 10 (27.8) | |
| > 3 cm | 37 | 13 (34.2) | 9 (23.7) | 13 (34.2) | 2 (7.9) | |
| Cumulative surface of superficial peritoneal implants | ||||||
| 0 | 113 | 46 (40.7) | 19 (16.8) | 27 (23.9) | 21 (18.6) | 0.48 |
| < 3 cm | 4 | 1 (25) | 0 | 3 (75) | 0 | |
| > 3 cm | 5 | 3 (60) | 1 (20) | 1 (20) | 0 | |
| Endometrioma | ||||||
| None | 26 | 11 (42.3) | 2 (7.7) | 9 (34.6) | 4 (15.4) | 0.14 |
| Unilateral | 61 | 23 (37.7) | 13 (21.3) | 11 (18) | 14 (23) | |
| Bilateral | 40 | 18 (45) | 7 (17.5) | 12 (30) | 3 (7.5) | |
| Cumulative size of endometriomas | ||||||
| 0 | 26 | 11 (42.3) | 2 (7.7) | 9 (34.6) | 4 (15.4) | 0.52 |
| ≤ 3 cm | 22 | 10 (45.5) | 3 (13.6) | 7 (31.8) | 2 (9.1) | |
| > 3 cm | 76 | 29 (38.2) | 16 (21.1) | 16 (21.1) | 15 (19.7) | |
| Size of the largest endometrioma | ||||||
| 0 | 24 | 10 (41.7) | 1 (4.2) | 9 (37.5) | 4 (16.7) | 0.30 |
| ≤ 3 cm | 36 | 16 (44.4) | 5 (13.9) | 7 (19.4) | 8 (22.2) | |
| > 3 cm | 64 | 24 (37.5) | 15 (23.4) | 16 (25) | 9 (14.1) | |
| Douglas obliteration | ||||||
| Absent | 16 | 7 (43.8) | 2 (12.5) | 5 (31.3) | 2 (12.5) | 0.06 |
| Partial | 48 | 12 (25) | 10 (20.8) | 18 (37.5) | 8 (16.7) | |
| Complete | 56 | 29 (51.8) | 8 (14.3) | 8 (14.3) | 11 (19.6) | |
| Cumulative size of posterior DIE | ||||||
| < 1 cm | 16 | 10 (62.5) | 3 (18.8) | 1 (6.3) | 2 (12.5) | 0.04 |
| 1–3 cm | 35 | 12 (34.3) | 4 (11.4) | 9 (25.7) | 10 (28.6) | |
| > 3 cm | 37 | 12 (32.4) | 9 (24.3) | 13 (35.1) | 3 (8.1) | |
| Sub peritoneal extension | ||||||
| Sub-peritoneal only | 72 | 35 (48.6) | 8 (11.1) | 15 (20.8) | 14 (19.4) | 0.07 |
| Rectal | 42 | 13 (31) | 11 (26.2) | 13 (31) | 5 (11.9) | |
| Vaginal | 1 | 0 | 0 | 0 | 1 (100) | |
| Both rectal and vaginal | 2 | 1 (50) | 0 | 1 (50) | 0 | |
| Chronic pelvic pain severity | ||||||
| The cumulative size of DIE implants | ||||||
| < 1 cm | 23 | 15 (65.2) | 6 (26.1) | 1 (4.3) | 1 (4.3) | 0.07 |
| 1–3 cm | 46 | 24 (52.2) | 6 (13) | 13 (28.3) | 3 (6.5) | |
| > 3 cm | 41 | 19 (46.3) | 14 (34.1) | 5 (12.2) | 3 (7.3) | |
| The cumulative surface of superficial peritoneal implants | ||||||
| 0 | 142 | 74 (52.1) | 27 (19) | 30 (21.1) | 11 (7.7) | 0.26 |
| < 3 cm | 5 | 2 (40) | 3 (60) | 0 | 0 | |
| > 3 cm | 5 | 3 (60) | 1 (20) | 0 | 1 (20) | |
| Endometrioma | ||||||
| None | 28 | 13 (46.6) | 4 (14.3) | 8 (28.6) | 3 (10.7) | 0.25 |
| Unilateral | 79 | 44 (55.7) | 15 (19) | 13 (16.5) | 7 (8.9) | |
| Bilateral | 50 | 22 (44) | 16 (32) | 10 (20) | 2 (4) | |
| The cumulative size of endometriomas | ||||||
| 0 | 28 | 13 (46.6) | 4 (14.3) | 8 (28.6) | 3 (10.7) | 0.68 |
| ≤ 3 cm | 26 | 15 (57.7) | 4 (15.4) | 5 (19.2) | 2 (7.7) | |
| > 3 cm | 100 | 51 (51) | 25 (25) | 17 (17) | 7 (7) | |
| Size of the largest endometrioma | ||||||
| 0 | 26 | 13 (50) | 2 (7.7) | 8 (30.8) | 3 (11.5) | 0.38 |
| ≤ 3 cm | 42 | 21 (50) | 10 (23.8) | 7 (16.7) | 4 (9.5) | |
| > 3 cm | 86 | 45 (52.3) | 21 (24.4) | 15 (17.4) | 5 (5.8) | |
| Douglas obliteration | ||||||
| Absent | 21 | 13 (61.9) | 2 (9.5) | 4 (19) | 2 (9.5) | 0.5 |
| Partial | 52 | 22 (42.3) | 15 (28.8) | 10 (19.2) | 5 (9.6) | |
| Complete | 76 | 43 (56.6) | 14 (18.4) | 14 (18.4) | 5 (6.6) | |
| Cumulative size of posterior DIE | ||||||
| < 1 cm | 23 | 15 (65.2) | 6 (26.1) | 1 (4.3) | 1 (4.3) | 0.03 |
| 1–3 cm | 45 | 24 (53.3) | 5 (11.1) | 13 (28.9) | 3 (6.7) | |
| > 3 cm | 40 | 18 (45) | 14 (35) | 5 (12.5) | 3 (7.5) | |
| Sub peritoneal extension | ||||||
| Sub-peritoneal only | 91 | 49 (53.3) | 18 (19.6) | 17 (18.5) | 8 (8.7) | 0.93 |
| Rectal | 51 | 25 (49) | 12 (23.5) | 11 (21.6) | 3 (5.9) | |
| Vaginal | 1 | 1 (100) | 0 | 0 | 0 | |
| Both rectal and vaginal | 2 | 1 (50) | 1 (50) | 0 | 0 | |
aRepresents the number and percentage of women with degree of severity of dysmenorrhea, dyspareunia, and chronic pelvic pain